Market News AIOpen the app

Abbott has started the VOYAGER clinical trial for its Encantor™ TAVI system to help patients with aortic stenosis.

TrialRead the original at prnewswire.com
Good for ABT

Abbott has started testing its Encantor™ heart valve system in a clinical study, advancing its development. The device is still investigational, and the study has not reported results.

ABT · Abbott Laboratories

AI read · Good for ABT

The AI's read

This gives Abbott a step forward in developing a heart valve device. The study will test safety and performance in patients. No results are reported yet, so any benefit depends on what the study finds.

Get alerts for ABT

Follow Abbott Laboratories (ABT) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for ABT
Free on the App Store and Google Play, or on the web.